DK1021444T3 - 5H-Pyrrolo-[2,1-c][1,4]benzodiazepin-3-carboxamidderivat - Google Patents

5H-Pyrrolo-[2,1-c][1,4]benzodiazepin-3-carboxamidderivat

Info

Publication number
DK1021444T3
DK1021444T3 DK97911809T DK97911809T DK1021444T3 DK 1021444 T3 DK1021444 T3 DK 1021444T3 DK 97911809 T DK97911809 T DK 97911809T DK 97911809 T DK97911809 T DK 97911809T DK 1021444 T3 DK1021444 T3 DK 1021444T3
Authority
DK
Denmark
Prior art keywords
benzodiazepine
pyrrolo
carboxamide derivative
carboxamide
derivative
Prior art date
Application number
DK97911809T
Other languages
Danish (da)
English (en)
Inventor
Eugene John Trybulski
Albert John Molinari
Jehan Framroz Bagli
Mark Anthony Ashwell
Thomas Joseph Caggiano
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1021444T3 publication Critical patent/DK1021444T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK97911809T 1996-11-01 1997-10-22 5H-Pyrrolo-[2,1-c][1,4]benzodiazepin-3-carboxamidderivat DK1021444T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74344396A 1996-11-01 1996-11-01
PCT/US1997/018918 WO1998020011A1 (fr) 1996-11-01 1997-10-22 DERIVES 3-CARBOXAMIDE DE 5H-PYRROLO[2,1-c][1,4]BENZODIAZEPINES

Publications (1)

Publication Number Publication Date
DK1021444T3 true DK1021444T3 (da) 2004-01-19

Family

ID=24988792

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97911809T DK1021444T3 (da) 1996-11-01 1997-10-22 5H-Pyrrolo-[2,1-c][1,4]benzodiazepin-3-carboxamidderivat

Country Status (19)

Country Link
EP (1) EP1021444B1 (fr)
JP (1) JP2001503759A (fr)
KR (1) KR20000052978A (fr)
CN (1) CN1330653C (fr)
AR (1) AR013329A1 (fr)
AT (1) ATE250607T1 (fr)
AU (1) AU737689B2 (fr)
BR (1) BR9713253A (fr)
CA (1) CA2268327C (fr)
DE (1) DE69725182T2 (fr)
DK (1) DK1021444T3 (fr)
ES (1) ES2206693T3 (fr)
HU (1) HUP9904514A3 (fr)
IL (1) IL129150A0 (fr)
NZ (1) NZ335483A (fr)
PT (1) PT1021444E (fr)
TW (1) TW496869B (fr)
WO (1) WO1998020011A1 (fr)
ZA (1) ZA979782B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001014336A1 (fr) * 1999-08-20 2001-03-01 Nippon Kayaku Kabushiki Kaisha Derives benzeniques substitues par un cycle aromatique, et leur procede de production
US6271418B1 (en) 2000-02-22 2001-08-07 Nippon Kayaku Co., Ltd. Process for preparing (hetero) aromatic substituted benzene derivatives
US6977254B2 (en) 2001-04-12 2005-12-20 Wyeth Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US7109193B2 (en) 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
US6900200B2 (en) 2001-04-12 2005-05-31 Wyeth Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7326700B2 (en) 2001-04-12 2008-02-05 Wyeth Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US6903087B2 (en) 2001-04-12 2005-06-07 Wyeth Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7202239B2 (en) 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US7064120B2 (en) * 2001-04-12 2006-06-20 Wyeth Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
GB0303852D0 (en) * 2003-02-19 2003-03-26 Pfizer Ltd Triazole compounds useful in therapy
GEP20074089B (en) * 2003-02-19 2007-04-10 Pfizer Triazole compounds useful in therapy
US7119088B2 (en) 2003-02-19 2006-10-10 Pfizer Inc. Triazole compounds useful in therapy
WO2009130232A1 (fr) * 2008-04-24 2009-10-29 Glaxo Group Limited Dérivés de pirazolo [1, 5 -a] pyrazine, antagonistes des récepteurs v1b

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516774A (en) * 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists

Also Published As

Publication number Publication date
HUP9904514A3 (en) 2000-10-30
DE69725182T2 (de) 2004-06-24
IL129150A0 (en) 2000-02-17
KR20000052978A (ko) 2000-08-25
EP1021444B1 (fr) 2003-09-24
CN1234801A (zh) 1999-11-10
EP1021444A1 (fr) 2000-07-26
PT1021444E (pt) 2004-02-27
DE69725182D1 (de) 2003-10-30
ATE250607T1 (de) 2003-10-15
BR9713253A (pt) 1999-11-03
TW496869B (en) 2002-08-01
ES2206693T3 (es) 2004-05-16
AU4909797A (en) 1998-05-29
AR013329A1 (es) 2000-12-27
HUP9904514A2 (hu) 2000-05-28
CN1330653C (zh) 2007-08-08
CA2268327A1 (fr) 1998-05-14
NZ335483A (en) 2001-09-28
JP2001503759A (ja) 2001-03-21
ZA979782B (en) 1999-04-30
WO1998020011A1 (fr) 1998-05-14
AU737689B2 (en) 2001-08-30
CA2268327C (fr) 2002-05-21

Similar Documents

Publication Publication Date Title
PT934320E (pt) Derivados de naftiridina
BR9708386A (pt) Derivados de 6-fenilpiridil-2-amina
IS4970A (is) Setnar 6,6-heteró-bísýklískar afleiður
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
ATE323682T1 (de) Aryl-pyrimidin-derivate
NO981946D0 (no) Imidazoquinazolin-derivater
ATE231847T1 (de) Substituierte 1,2,3,4- tetrahydronaphthalinderivate
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
BR9709065A (pt) Derivados de alquilaminobenzotiazole e-benzoxazol
PT922050E (pt) Derivados de 3-descladinose-2,3-anidroeritromicina
DK1021444T3 (da) 5H-Pyrrolo-[2,1-c][1,4]benzodiazepin-3-carboxamidderivat
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
PT931087E (pt) Novos derivados de piranosido
PT906279E (pt) Derivados de pirrol
MA26440A1 (fr) Derives de n-benzylazolium
BR9505178A (pt) Derivados de ciclolignan imunosupressivos
BR9701404A (pt) Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol
BR9706980A (pt) Derivados de isooxacefem
BR9708310A (pt) Derivados de 2-tioxotetrahidropirimidin-4-ona
BR9510036A (pt) Derivados de 1,3,4-oxadiazina
DE69704297D1 (de) 10,11-Dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamidderivate
BR9704674A (pt) Derivados de n-benzilazólio
ATA69896A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate
ATA73396A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate